12Jul 2024
What comes after sotorasib and adagrasib?

What comes after sotorasib and adagrasib?

This review highlights recent advancements in KRAS inhibitor development for NSCLC following the approval of sotorasib and adagrasib. Despite initial success, their efficacy is limited by resistance, prompting research into more potent inhibitors and combination therapies, including novel approaches like molecular shielding and immunological strategies.

  • #pulmonology

Like

Save

Share